皇冠428428娱乐娱城(中国)有限公司
/en/index.php?m=content&c=index&a=show&catid=143&id=667
Name Mingxiang Zhang
Title M.D., Ph.D., Professor, Ph.D. Advisor
Areas of Focus

 
A. Positions and Honors
 
Positions and Employment
1993-1996     Research Assistant,  Shandong Province Hospital
1996-1999     Research Associate, Shandong Province Hospital
2000-2001     Research Assistant Professor, Shandong Province Hospital
2002-2007     Research Associate, Baylor College of Medicine
2008-             Deputy Director, Professor,   Department of Cardiology, Shandong University Qilu Hospital, China
 
Other Experience and Professional Memberships
2008-present    Chinese Medical Association for Cardiology
2009-present American Heart Association (AHA)
2012-present World Federation of Chinese Medicine Societies
 
Honors
2012      Council Member of the 1st Board of World Federation of Chinese Medicine Societies
2019       Taishan Scholars
B.   Editorial Board and Reviewer
 
Editorial Board member
Frontiers in Pharmacology (Pharmacotherapy of Inflammation),  Associate Editor 2011-
Frontiers in Vascular Physiology                                          Associate Editor 2011-
Ad hoc Reviewer
International Research Journal of Biotechnology 
Journal of Biological Chemistry;
Prostaglandins and Other Lipid Mediators;
FASEB Journal;
Pharmaceutical Research;
Journal of Endocrinology;
Journal of Cellular Physiology;
FEBS Letters;
 
C. Current Grant Support
 
2009CB521900    Zhang Ming-xiang (PI)     1/1/2009-12/31/2013
The Ministry of Science and Technology of China 
Atherosclerotic Plaque Stabilization and Stroke
The major goal in this project is to address comprehensively the role of Atherosclerotic Plaque Stabilization and stroke protection.
 
30071037            Zhang Ming-xiang (PI)             1/1/2009-12/31/2011
National Natural Science Foundation of China 
27-nt repeats small nuclear RNA specifically regulating eNOS expression and endothelial function
The major goal in this project is to address intron-based microRNAs in eNOS can induce significant gene specific transcriptional suppression, which could be an effective negative feedback regulator for gene expression and endothelial function
 
91439201           Zhang Ming-xiang (PI)   1/1/2015-12/31/2018
National Natural Science Foundation of China 
Endothelial-to-Mesenchymal Transition on Cardiovascular Atherosclerosis in Diabetes Mellitus
The major goal in this project is to address the roles of Endothelial-to-Mesenchymal transition on cardiovascular atherosclerosis in diabetes mellitus.
 
81370412            Zhang Ming-xiang (PI)    1/1/2014-12/31/2017
National Natural Science Foundation of China 
PARP-1 Mediates TFPI-2 Transcription and Regulates MMPs Activity in Diabetic Vascular Intimal Hyperplasia
The major goal in this project is to address the role of PARP-1 in diabetic vascular intimal hyperplasia